| Stage | ALSN | % of rev | MTCH | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $1.6B | 100.00% | $853M | 100.00% | ALSN ×1.84 |
| Gross profit | $515M | 32.89% | $649M | 76.06% | MTCH +43.2pp |
| Operating income | $291M | 18.58% | $245M | 28.77% | MTCH +10.2pp |
| Pre-tax income | $228M | 14.56% | $215M | 25.16% | MTCH +10.6pp |
| Net income | $181M | 11.56% | $171M | 19.99% | MTCH +8.4pp |
| Stage | ALSN | MTCH | Gap · A − B |
|---|---|---|---|
| Revenue | $1.6B100.00% | $853M100.00% | ALSN ×1.84 |
| Gross profit | 32.89%$515M | 76.06%$649M | MTCH +43.2pp |
| Operating income | 18.58%$291M | 28.77%$245M | MTCH +10.2pp |
| Pre-tax income | 14.56%$228M | 25.16%$215M | MTCH +10.6pp |
| Net income |
| 11.56%$181M |
| 19.99%$171M |
| MTCH +8.4pp |
No shared counterparties.